Crime and justice
We work with a number of partners across our workstreams
You'll find an update on our recent work into crime and justice below.
A baseline audit (2024-2025) of all Welsh prison mental health services and substance misuse teams was commissioned by Welsh Government, this was to support commitments within the Prison Partnership Agreement between Welsh Government and HMPPS. The audit was conducted by CCQI, and undertaken in partnership with Dyfodol and NHS Wales' Joint Commissioning Committee (JCC).
The work was designed to identify similarities and differences between models of care across Welsh prisons, consider where services are performing well and why, and identify thematic areas which may require additional resource or support. The audit was conducted against existing standards developed by the Quality Network for Prison Mental Health services that were adapted to capture services in Wales more effectively. New principles were also incorporated for both mental health and substance misuse teams with involvement from Dyfodol, Welsh Government, and the JCC.
The audit report was designed to summarise findings from reviews of each of the prison mental health and substance misuse teams in Wales. It presents an analysis of how well member services were performing against the quality standards, as well as areas of best practice identified and recommendations relating to commonly unmet criteria. Recommendations were designed to support Welsh Government in making decisions regarding the funding and support available to prison mental health and substance misuse services based on themes arising across the visits.
A set of quality standards was developed as a framework against which all prison mental health and substance misuse services in Wales were assessed.
They are based on existing standards owned by the Quality Network for Prison Mental Health services which have been adapted to capture services in Wales more effectively. New principles have also been incorporated for both mental health and substance misuse teams with involvement from Dyfodol, Welsh Government, and NHS Wales' Joint Commissioning Committee.